Potential mechanisms of active components from traditional Chinese medicine in acute myeloid leukemia via ferroptosis: an integrative bioinformatics and molecular modeling study
Abstract
BackgroundAcute myeloid leukemia (AML) represents a heterogeneous hematologic malignancy with divergent clinical outcomes. The prognostic significance of ferroptosis-associated genes and bioactive compounds derived from traditional Chinese medicine (TCM) in AML has not been fully characterized. We sought to construct an AML prognostic model by integrating ferroptosis-related genes with TCM molecular targets and to investigate the mechanistic basis underlying their interactions.MethodsTranscriptomic data were obtained from TCGA-LAML, GSE114868 (training cohorts) and GSE71014 (validation cohort). Candidate genes were screened by overlapping differentially expressed genes, ferroptosis-related gene sets and TCM target databases. Analyses included prognostic gene selection, model construction and validation, nomogram establishment, immune microenvironment profiling, gene set enrichment analysis (GSEA), Mendelian randomization (MR), molecular docking and molecular dynamics (MD) simulations. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used to validate gene expression.ResultsCDKN1A and HMOX1 were identified as key prognostic genes, and the model showed stable predictive performance. Risk scores were correlated with age, and both genes independently predicted AML prognosis. The high-risk group had an immunosuppressive microenvironment. The two genes were enriched in ferroptosis pathways. MR analysis suggested a potential causal association between CDKN1A and AML (IVW P = 0.0104), whereas HMOX1 did not reach statistical significance (IVW P = 0.109). Quercetin and luteolin showed potential binding to the target proteins. RT-qPCR suggested lower CDKN1A and HMOX1 expression in a small AML cohort; these findings require validation in larger cohorts.ConclusionThe CDKN1A and HMOX1-based prognostic model showed potential for stratifying AML patients in exploratory analyses. TCM bioactive components may target these genes and regulate ferroptosis pathways, but these mechanisms remain hypothetical and require experimental validation.
Related
- Integrative Multi-Database Bioinformatics Characterization of FANCE in Hepatocellular Carcinoma: Prognostic, Epigenetic, Immune, and ncRNA Associations
- Integrative bioinformatics analysis of Lianmei granules in diabetic nephropathy : Epidemiological and molecular insights
- Identification of SLC15A3 as a shared prognostic biomarker for AML and COVID-19 via integrative bioinformatics, machine learning and Mendelian randomization
- Integrative network toxicology and bioinformatics reveal the potential toxicological effects of aspartame on hyperuricemia
- GSTP1 as a senescence-associated diagnostic candidate in prostate cancer: integrative bioinformatics and functional validation
BibTeX
@article{xie2026potential,
title = {{Potential mechanisms of active components from traditional Chinese medicine in acute myeloid leukemia via ferroptosis: an integrative bioinformatics and molecular modeling study}},
author = {Baozhen Xie and Xiangfan Chen and Bin Liao and Yan Qi and Yining Chen},
journal = {Frontiers in Oncology},
year = {2026},
month = nov,
doi = {10.3389/fonc.2026.2000304},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.2000304},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Potential mechanisms of active components from traditional Chinese medicine in acute myeloid leukemia via ferroptosis: an integrative bioinformatics and molecular modeling study
AU - Baozhen Xie
AU - Xiangfan Chen
AU - Bin Liao
AU - Yan Qi
AU - Yining Chen
PY - 2026
DA - 2026/11/12
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.2000304
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.2000304
AB - BackgroundAcute myeloid leukemia (AML) represents a heterogeneous hematologic malignancy with divergent clinical outcomes. The prognostic significance of ferroptosis-associated genes and bioactive compounds derived from traditional Chinese medicine (TCM) in AML has not been fully characterized. We sought to construct an AML prognostic model by integrating ferroptosis-related genes with TCM molecular targets and to investigate the mechanistic basis underlying their interactions.MethodsTranscriptomic data were obtained from TCGA-LAML, GSE114868 (training cohorts) and GSE71014 (validation cohort). Candidate genes were screened by overlapping differentially expressed genes, ferroptosis-related gene sets and TCM target databases. Analyses included prognostic gene selection, model construction and validation, nomogram establishment, immune microenvironment profiling, gene set enrichment analysis (GSEA), Mendelian randomization (MR), molecular docking and molecular dynamics (MD) simulations. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used to validate gene expression.ResultsCDKN1A and HMOX1 were identified as key prognostic genes, and the model showed stable predictive performance. Risk scores were correlated with age, and both genes independently predicted AML prognosis. The high-risk group had an immunosuppressive microenvironment. The two genes were enriched in ferroptosis pathways. MR analysis suggested a potential causal association between CDKN1A and AML (IVW P = 0.0104), whereas HMOX1 did not reach statistical significance (IVW P = 0.109). Quercetin and luteolin showed potential binding to the target proteins. RT-qPCR suggested lower CDKN1A and HMOX1 expression in a small AML cohort; these findings require validation in larger cohorts.ConclusionThe CDKN1A and HMOX1-based prognostic model showed potential for stratifying AML patients in exploratory analyses. TCM bioactive components may target these genes and regulate ferroptosis pathways, but these mechanisms remain hypothetical and require experimental validation.
SN - 2234-943X
ER -